Champlain Investment Partners, LLC

Champlain Investment Partners is an independent, employee-owned asset management firm headquartered in Burlington, Vermont. Our investment strategies are designed to focus on providing absolute returns while also managing risk. We strive to create wealth through the consistent execution of our investment process; we are equally committed to delivering outstanding client service, and pride ourselves on the many long-standing relationships we have been able to cultivate since opening our doors in 2004. Our partners bring a wealth of experience, averaging over 23 years in asset management, and as of 03.31.23 the firm had approximately $16.56 billion in assets under management.

Abouhamela Group

نحن نؤمن ان النجاح ليس له حدود وانه الابداع لا نهايه له \\- *تأسست المجموعه عام 1994 واضعه نصب عينيها ان تصبح بحلول عام 2020 واحده من كبرى المؤسسات العالميه الرائده في مجالات الاستثمار و التجاره و التنميه.\\- *ولقصه نجاحنا طوال 25 عاما معالم هامه باختراقنا المبكر لعالم التكولوجيا و الالكترونيات و المجال الطبي تصنيعا وتجاره و توزيعا مؤثرين بذلك في الاسواق العالميه والمحليه من خلال مجموعه شركات المؤسسه و قنوات توزعيها في الامارات و السعوديه و مصر \\واليوم وامتدادا لرؤية 25 عاما ختت, نضع حجر الأساس لمهمتنا الجديده في تطوير اعمالنا تاسست احدث شركات المجموعه سمارت جيت سوليوشن و مكاني للتطوير و الاستثمار العقاري و سوفت لاين للحلول المتكامله و ذلك كحجر زاوية في رؤية المجموعه لسنة 2050\\\We believe that success has no limits & innovation has no end!\\We launched in 1994 aiming to become one of the world's leading conglomerates in the fields of Investment, Trading & Development by 2020.\\In the past 25 years we were able to prove our success in the main industries that affect the global market, Electronics & Technology and Manufacturing of ortho-surgeon supplies. In these fields, we were willing to contribute in the growth of the local market as well, by building the main factory of AMSEO in Egypt. This factory was built to match the standards of German production & distributed among different channels across Egypt & the MENA region.\\Upon this success, we have set our new vision of 2050 that we are willing to achieve through the contribution of our recently launched companies Smart Gate Solutions, Makany Real Estate & Development & Soft-line solutions!\\

Scheidler Medical Preferred

River Grove School Dist 85-5

River Grove School Dist 85-5 is an education management company based out of 2650 Thatcher Ave, River Grove, IL, United States.

DSI - DS InPharmatics, a PLG company

DS InPharmatics (DSI) offers one-stop, full-service CMC consulting resources to emerging pharmaceutical and biopharmaceutical companies. The exceptional value DS InPharmatics offers begins with our dedicated, multidisciplinary teams of manufacturing, quality, and regulatory affairs specialists. Our CMC consultants combine in-depth technical knowledge of product development with risk-based submission content and regulatory strategies for all phases of the review and approval process. This breadth of pharmaceutical development expertise provides you with a single, integrated source for efficient problem-solving strategies and scientific expertise. Whether your needs are comprehensive or tightly focused on a specific project, our experienced CMC consultants will help keep your drug development program on track. Not just advice. DSI provides you with hands-on, flexible resources and expanded operational capability, to implement a compliant drug development strategy and timelines. In April 2021 we were thrilled to announce that DSI has just become part of ProductLife Group. Our merger with PLG will harness our combined strengths, offering our clients on both sides of the Atlantic support with their developed drugs approvals and post-approvals compliance, plus advisory services on the best market strategies to deliver a rapid ROI on their development. Together we will offer our clients increased pharmacovigilance capabilities - including a QPPV; pharmacovigilance consulting; and a fully validated safety database – as well as complementary toxicology-related services; RIM/electronic document management services; and support for medical device regulatory requirements. We see enormous potential in this new chapter for DSI and for you, our clients. As a PLG company, we have the opportunity to become part of a global force in life sciences regulatory and compliance solutions and services, and we're incredibly excited to add our momentum to that effort.